In addition, recombinant Klotho treatment countered inflammation and cell death induced by permanent cardiac ischemia, supporting Klotho supplementation as a promising therapeutic strategy to globally prevent the deleterious consequences of IHD after a MI. Here, KL is linked to myocardial ischemia.